Loading
A phase 2 trial of FOLFOXIRI and cAPOX (capecitabine, oxaliplatin) in colorectal cancer, run by West China Hospital, now recruiting.
CtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial) is a phase 2, randomised interventional study registered as NCT06242418 by West China Hospital, with a registry enrolment figure of 60 participants, started 2024-03-25 and due to reach its primary completion in 2025-12-31. Interventions recorded: FOLFOXIRI; XELOX. Conditions listed: Colon Cancer. Primary outcome: change in value of ctDNA concentration. Colorectal eligibility wording from the registry: "Tumor located in the colon (the distance from the lower margin of the tumor to the anus is greater than 12 cm)". Sites: China. No results are recorded here; the registry entry is the source.
Shares FOLFOXIRI (5-FU, leucovorin, oxaliplatin, irinotecan), CAPOX (capecitabine, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents and the tag colorectal-deep-dive.
Shares FOLFOXIRI (5-FU, leucovorin, oxaliplatin, irinotecan), CAPOX (capecitabine, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents and the tag colorectal-deep-dive.
Shares FOLFOXIRI (5-FU, leucovorin, oxaliplatin, irinotecan), CAPOX (capecitabine, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents and the tag colorectal-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), MRD / molecular residual disease testing, Platinum agents, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares FOLFOXIRI (5-FU, leucovorin, oxaliplatin, irinotecan), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares FOLFOXIRI (5-FU, leucovorin, oxaliplatin, irinotecan), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares FOLFOXIRI (5-FU, leucovorin, oxaliplatin, irinotecan), CAPOX (capecitabine, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents and the tag colorectal-deep-dive.
Shares FOLFOXIRI (5-FU, leucovorin, oxaliplatin, irinotecan), Topoisomerase-I inhibitors (and ADC payloads), Platinum agents, Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.